Description: Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation. Brainsway Ltd. was founded in 2003 and is based in Jerusalem, Israel.
Home Page: www.brainsway.com
Bynet Building
Jerusalem,
9777518
Israel
Phone:
972 2 582 4030
Officers
| Name | Title |
|---|---|
| Mr. Hadar Levy | Chief Executive Officer |
| Mr. Avner Hagai | Founder & Director |
| Prof. Abraham Zangen | Co-Founder, Member of Scientific Advisory Board & Director |
| Dr. Yiftach Roth Ph.D. | Founder & Chief Scientific Officer |
| Mr. Ido Marom | Chief Financial Officer |
| Mr. Gilead Moiseyev | Chief Technology Officer |
| Mr. Menachem C. Klein Esq. | VP, General Counsel & Corporate Secretary |
| Mr. Ross Mitchell | Vice President of Global Marketing |
| Ms. Hillegonda Groen | Vice President of International Sales |
| Dr. Richard A. Bermudes M.D. | Chief Medical Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 46.729 |
|---|---|
| Trailing PE: | 213.25 |
| Price-to-Book MRQ: | 2.6919 |
| Price-to-Sales TTM: | 2.7686 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 134 |